HCM
BSX icon

Highlander Capital Management’s Boston Scientific BSX Stock Holding History

Highlander Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$6.85K Hold
100
– – ﹤0.01% 755
2023
Q4 		$5.78K Hold
100
– – ﹤0.01% 792
2023
Q3 		$5K Buy
+100
New +$5.25K ﹤0.01% 757

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Highlander Capital Management's BSX Position: Q1 2024 in Review

Highlander Capital Management held its Boston Scientific (BSX) position steady in Q1 2024 at 100 shares worth $6.85K. The position accounts for ﹤0.01% of the portfolio, ranked #755.

Highlander Capital Management first reported a position in BSX in Q3 2023 and has held it in 3 quarters since. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Highlander Capital Management held 100 shares of Boston Scientific worth $6.85K as of Q1 2024.
  • Highlander Capital Management left its Boston Scientific share count unchanged in Q1 2024.
  • Boston Scientific made up ﹤0.01% of Highlander Capital Management's portfolio in Q1 2024, its #755 holding.
  • Highlander Capital Management first reported a position in Boston Scientific in Q3 2023 and has held it in 3 quarters since.
  • 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.